Go Pro
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel
NASDAQ:LNAI

Lunai Bioworks Q2 2026 Earnings Report

Lunai Bioworks logo
$2.43 -0.05 (-2.02%)
As of 10:45 AM Eastern
This is a fair market value price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

Lunai Bioworks EPS Results

Actual EPS
-$0.64
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Lunai Bioworks Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Lunai Bioworks Announcement Details

Quarter
Q2 2026
Date
2/17/2026
Time
During Market Hours
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Lunai Bioworks Earnings Headlines

Lunai Bioworks (NASDAQ:LNAI) Stock Price Down 2.7% - Here's Why
August 6 at 4:01 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30944868
Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement with BrainStorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027
August 4 at 3:28 PM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/lunai-bioworks-nasdaq-lnai-signs-definitive-collaboration-agreement-with-brainstorm-therapeutics-initial-parkinsons-disease-data-readout-targeted-for-first-half-of-2027-302842928.html
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.tc pixel
August 6 at 1:00 AM  |  Investors Alley (Ad)
Lunai Bioworks (Nasdaq: LNAI) Names 10 Defendants in Naked Short Selling Fraud Suit
August 4 at 9:20 AM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/lunai-bioworks-nasdaq-lnai-names-10-defendants-in-naked-short-selling-fraud-suit-302842515.html
Why Did LNAI Stock Soar Over 100% In Pre-Market Trading Today?
June 17, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/why-did-lnai-stock-soar-103010047.html
Lunai Bioworks (LNAI) Stock Is Trending Overnight — Here's Why It Spiked Nearly 81% In After-Hours Session
June 17, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/lunai-bioworks-lnai-stock-is-trending-overnight-here-s-why-it-spiked-nearly-81-in-after-hours-session/ar-AA25Qb8P
See More Lunai Bioworks Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Lunai Bioworks? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lunai Bioworks and other key companies, straight to your email.

About Lunai Bioworks

Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for autologous HIV curative treatment; ENOB-HV-11, a preventative HIV vaccine; ENOB-HV-12, a therapeutic HIV vaccine; and ENOB-HB-01, a coopting HBV polymerase. Its pipeline development products comprise ENOB-DC-11 off the shelf DC vaccine for multiple solid tumors; and ENOB-DC-21, a non-specific vaccine for intraturmoral injection. Enochian Biosciences, Inc. has strategic partnerships with The Scripps Institute, Fred Hutchinson Cancer Research Center, the Texas Biomedical Research Institute, the University of California, Los Angeles, and The Hepatitis B Foundation and Baruch S. Blumberg Institute. The company was incorporated in 2017 and is headquartered in Los Angeles, California.

View Lunai Bioworks Profile
Earnings Tools